11/28/2011 11:21:44 AM
TIRAT CARMEL, Israel, Nov. 28, 2011 (GLOBE NEWSWIRE) -- D. Medical Industries Ltd. (Nasdaq:DMED - News) (TASE:DMED - News) ("D. Medical" or the "Company"), a medical device company engaged through its subsidiaries in the research, development, manufacture and sale of innovative products for diabetes treatment and drug delivery, announced today that it has been granted U.S. Patent No. 8050729, entitled "Devices For Continuous Measurement of Glucose in Body Fluid." This patent protects innovative technology that allows for the combination of a minimally invasive Continuous Glucose Monitor and an insulin pump on the same "patch." Amongst other features, the technology enables the use of a single access point to both accurately test for blood glucose levels and deliver insulin.
comments powered by